Table 4.

Demographic and clinical details for each focus group. Details for each participant include age, gender, etiology of amputation, level of amputation (HD = hip disarticulation, TF = transfemoral, TD = knee disarticulation, TT = transtibial), and years since amputation

Focus group 1

PT1.1:64, M, Trauma, TT, 14.3

PT1.2: 33, M, Infection, Bilateral TT, 10.8

PT1.3: 60, F, Not provided, TT, 60.5

PT1.4:55, M, Tumor, TF, 12.8

PT1.5:54, F, Infection, TT, 7.6

PT1.6: 31, M, Trauma, Bilateral TF/HD, 7.0

Focus group 2

PT2.1:44, M, Trauma, TT, 3.5

PT2.2: 51, M, Trauma, TT, 33.9

PT2.3: 44, M, Trauma, TT, 12.4

PT2.4: 43, F, Trauma, TF, 12.5

PT2.5: 26, M, Trauma, TT, 16.4

PT2.6: 48, M, Trauma, TT, 4.3

PT2.7: 33, M, Infection, Bilateral TT/TT, 14.7

PT2.8:41, M, Trauma, TT, 3.2

PT2.9:30, M, Trauma, TF, 1.0

Focus group 3

PT3.1:56, M, Trauma, TF, 7.1

PT3.2: 41, F, Not provided, TT, 1.4

PT3.3:41, F, Trauma, TT, 2.6

PT3.4: 49, M, Infection, Bilateral TT/TT, 11.3

PT3.5: 71, M, Peripheral Vascular Disease, TT, 9.2

PT3.6: 53, M, Infection, HD, 0.6

PT3.7: 65, M, Blood clot, TT, 5.2

PT3.8: 45, M, Trauma, TT, 0.7

PT3.9: 22, M, Trauma, TT, 0.9

PT3.10: 61, M, Peripheral Vascular Disease, TT, 2.4

PT3.11:47, F, Tumor, TT, 7.1

PT3.12: 57, F, Trauma, TT, 9.0

Focus group 4

PT4.1: 49, M, Trauma, TF, 26.7

PT4.2: 62, F, Trauma, TF, 43.1

PT4.3: 60, M, Infection, Bilateral TT/TT, 17.6

PT4.4: 65, F, Peripheral Vascular Disease, TT, 7.4

PT4.5: 62, F, Trauma, TF, 9.4

PT4.6: 53, M, Not provided. Bilateral KD/TT, 51.1

PT4.7: 62, F, Peripheral Vascular Disease, Bilateral TF/TK, 22.2 (TF), 3.7 (TK)

PT4.8: 70, M, Trauma/Infection, TT, 22.6

PT4.9: 62, M, Trauma, TF, 35.9

PT4.10: 55, M, Trauma, Bilateral TT/TT, 34.4